Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Genocea Biosciences, Inc. (GNCA)

« Back to company index

GNCA Chatter Timeline

Stock Ticker for GNCA

Most Active Tweeters for GNCA

UserTweets
@Lin_ling_88 10
@Gambiste1 4
@SelfThink4 2
@ThisLincolnian 2
@ConsumerFeed 2

Recent Tweets for GNCA

st_kinne @st_kinne
$GNCA- I’m stalking this one as well.
July 15th 2019, 3:07pm
Gambiste1 @Gambiste1
RT @TekATL3: $GNCA may share, before the pop to 11 https://t.co/DBo5ugGi4j
July 13th 2019, 2:07am
TekATL3 @TekATL3
$GNCA may share, before the pop to 11 https://t.co/DBo5ugGi4j
July 12th 2019, 11:07pm
AmericanBanking @AmericanBanking
Genocea Biosciences Inc $GNCA Short Interest Up 25.4% in June https://t.co/759cc4ZhSB #stocks
July 12th 2019, 8:07pm
ThisLincolnian @ThisLincolnian
Genocea Biosciences Inc $GNCA Short Interest Up 25.4% in June https://t.co/iq6oFrC1K1
July 12th 2019, 8:07pm
SelfThink4 @SelfThink4
$GNCA no support yet. ? In a serious Downtrend now. https://t.co/yy2CXofMGO
July 12th 2019, 3:07pm
r_holliday2 @r_holliday2
$GNCA Added more this morning. It's cheap. It's all about playing the probabilities of success, and I like their ch… https://t.co/894oMIBUzv
July 12th 2019, 1:07pm
ThisLincolnian @ThisLincolnian
Genocea Biosciences $GNCA Now Covered by Stifel Nicolaus https://t.co/LgvWUaBKWj
July 12th 2019, 8:07am
ConsumerFeed @ConsumerFeed
Genocea Biosciences $GNCA Now Covered by Stifel Nicolaus https://t.co/SfdrsLTXql
July 12th 2019, 8:07am
SelfThink4 @SelfThink4
$GNCA ugly breakdown. $3.50 level is possibly next. https://t.co/WinPlIA3o5
July 11th 2019, 8:07pm
Lin_ling_88 @Lin_ling_88
RT @OneMdcn: $GNCA New July Presentation Slide Deck https://t.co/Mc5phTevjW
July 11th 2019, 8:07pm
bbnsnews @bbnsnews
Genocea Biosciences $GNCA Earns Buy Rating from Analysts at Stifel Nicolaus https://t.co/LxS5wSQZGn
July 11th 2019, 8:07pm
OneMdcn @OneMdcn
$GNCA New July Presentation Slide Deck https://t.co/Mc5phTevjW
July 11th 2019, 11:07am
StockflareUS @StockflareUS
$GNCA: The recommendation for Genocea Biosciences Inc has been upgraded to Strong Buy. (https://t.co/6vJYoItWZ6)
July 9th 2019, 6:07am
Gambiste1 @Gambiste1
RT @ez_scans: $GNCA (( l4_lbbb ))=lower bband bounce
July 8th 2019, 2:07pm
firsttomarkets @firsttomarkets
Genocea Biosciences Inc Reiterated Rating by Stifel Nicolaus (Ranked 34th) to Buy with $13PT $GNCA #GNCA https://t.co/25mq3Ybhmi
July 8th 2019, 10:07am
TopStockAlerts1 @TopStockAlerts1
$GNCA Keep an eye on it for today! https://t.co/ZKx6HyHoXo
July 8th 2019, 9:07am
Lin_ling_88 @Lin_ling_88
Dana Farber article also bodes well for $GNCA: - GEN009 + combo study w/checkpoint inhibitor (5 target indicatio… https://t.co/P3uv8obabp
July 8th 2019, 8:07am
Gambiste1 @Gambiste1
RT @Lin_ling_88: The collaborative program between $IOVA and $GNCA on GEN-011 to aim at optimized neoAg-based cell therapy for solid & heme…
July 8th 2019, 5:07am
Lin_ling_88 @Lin_ling_88
The collaborative program between $IOVA and $GNCA on GEN-011 to aim at optimized neoAg-based cell therapy for solid… https://t.co/TWQuyWJIHS
July 8th 2019, 1:07am
dakotafinancial @dakotafinancial
Analysts Anticipate Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/tcuB1HV9NF
July 7th 2019, 8:07pm
r_holliday2 @r_holliday2
RT @Lin_ling_88: $GNCA to give oral presentation at upcoming “Targeted Therapies - Immuno-Oncology Summit” 2019, August 8-9, Boston 8/8,…
July 7th 2019, 7:07pm
Gambiste1 @Gambiste1
RT @Lin_ling_88: $GNCA oral presentation (continued) Genocea is applying ATLAS in its two lead programs: GEN-009, a neoantigen vaccine cu…
July 7th 2019, 6:07pm
Lin_ling_88 @Lin_ling_88
$GNCA oral presentation (continued) Genocea is applying ATLAS in its two lead programs: GEN-009, a neoantigen vac… https://t.co/WUQwtyHq8a
July 7th 2019, 6:07pm
Lin_ling_88 @Lin_ling_88
$GNCA presentation (continued) Excluding inhibitory peptides that may suppress tumor immunity, accelerate tumor pr… https://t.co/d9TleQz1du
July 7th 2019, 6:07pm
Lin_ling_88 @Lin_ling_88
$GNCA: brief description of presentation att the I-O Summit: Genocea’s ATLAST platform is a powerful tool that sc… https://t.co/fzIpERd2kx
July 7th 2019, 6:07pm
Lin_ling_88 @Lin_ling_88
$GNCA to give oral presentation at upcoming “Targeted Therapies - Immuno-Oncology Summit” 2019, August 8-9, Boston… https://t.co/PfyFxvpbfu
July 7th 2019, 6:07pm
WatchlistN @WatchlistN
Genocea Biosciences $GNCA Raised to “Buy” at Zacks Investment Research https://t.co/tt9HZk5vXO
July 7th 2019, 5:07am
macondailynews @macondailynews
Genocea Biosciences $GNCA Raised to “Buy” at Zacks Investment Research https://t.co/PQROmx6yUr
July 6th 2019, 8:07am
macondailynews @macondailynews
Genocea Biosciences $GNCA Rating Lowered to Sell at ValuEngine https://t.co/t8uR5gFihl
July 6th 2019, 6:07am
TickerReport @TickerReport
Genocea Biosciences $GNCA Rating Lowered to Sell at ValuEngine https://t.co/Cutd3tRmJi
July 6th 2019, 6:07am
TheMarketsDaily @TheMarketsDaily
Genocea Biosciences $GNCA Rating Lowered to Sell at ValuEngine https://t.co/z9b3TuyFRR
July 6th 2019, 6:07am
midetimes @midetimes
Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/jdb7CLg674 #stocks
July 5th 2019, 7:07pm
dailymailtimes @dailymailtimes
Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/MO0BKleVmo #investing
July 5th 2019, 7:07pm
dailypoliticaln @dailypoliticaln
Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/HBNJMJKCIx
July 5th 2019, 7:07pm
ZolmaxNews @ZolmaxNews
Zacks: Analysts Anticipate Genocea Biosciences Inc $GNCA Will Announce Earnings of -$0.78 Per Share https://t.co/ZwmUS8HuyM
July 5th 2019, 7:07pm
WKRBNews @WKRBNews
Brokerages Expect Genocea Biosciences Inc $GNCA to Announce -$0.78 EPS https://t.co/MyEYKh1GO7 #markets
July 5th 2019, 7:07pm
ProTradersNews @ProTradersNews
$GNCA: What Type Of Shareholder Owns Genocea Biosciences, Inc.’s …: https://t.co/cmBNs6TeMs
July 5th 2019, 3:07pm
ez_scans @ez_scans
$GNCA (( l4_lbbb ))=lower bband bounce
July 5th 2019, 9:07am
WKRBNews @WKRBNews
Genocea Biosciences $GNCA Cut to “Sell” at ValuEngine https://t.co/Y9dB7bZ1E0 #markets
July 5th 2019, 9:07am
OneMdcn @OneMdcn
RT @Lin_ling_88: @thejadedtrader $GNCA: totally agreed. I am not aware of any cases or precedent where (powerfully) elicited CD8+ T cell re…
July 5th 2019, 6:07am
TickerReport @TickerReport
Zacks Investment Research Upgrades Genocea Biosciences $GNCA to Buy https://t.co/p5qfWDPQdO
July 5th 2019, 4:07am
ConsumerFeed @ConsumerFeed
Zacks Investment Research Upgrades Genocea Biosciences $GNCA to Buy https://t.co/LEPNqIAnLN
July 5th 2019, 4:07am
Lin_ling_88 @Lin_ling_88
@thejadedtrader $GNCA: totally agreed. I am not aware of any cases or precedent where (powerfully) elicited CD8+ T… https://t.co/QYsNR5UYEd
July 4th 2019, 11:07pm
Lin_ling_88 @Lin_ling_88
Short Interest in $GNCA Declines By 87.2%. Also.... ??Major shareholder Peter Sonsini bought 2,857,142 shares of G… https://t.co/5ok2dt9XXC
July 4th 2019, 6:07pm
thejadedtrader @thejadedtrader
$GNCA still the only screen capable of detecting inhibitory neoantigens. Huge value for solid tumor ACT’s that targ… https://t.co/KuwgQpfoeR
July 4th 2019, 4:07pm
Lin_ling_88 @Lin_ling_88
@rogerthat191 No way you can compare CAPR with $GNCA...orders of magnitude in difference.
July 4th 2019, 12:07pm
dakotafinancial @dakotafinancial
Genocea Biosciences $GNCA Stock Rating Lowered by ValuEngine https://t.co/mZvixjEO2A
July 4th 2019, 8:07am
TopStockAlerts1 @TopStockAlerts1
$GNCA setting up! https://t.co/ZKx6HyHoXo
July 3rd 2019, 12:07am
ChartMill @ChartMill
$GNCA: Comparing the growth rate of the last 5 years to the rate of the upcoming 2 years, we see that the growt ...… https://t.co/TPHG8sedje
July 2nd 2019, 11:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.